Previous research has indicated that high CDH17 expression in tumor tissues is correlated with poorer prognosis and survival in patients with colorectal cancer, cholangiocarcinoma, and hepatocellular carcinoma [17, 18]. Here, CDH17 is linked to hepatocellular carcinoma.